Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2005
03/10/2005WO2005020994A1 Solid dispersions comprising tacrolimus
03/10/2005WO2005020993A1 Modified release compositions comprising tacrolimus
03/10/2005WO2005020882A2 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005WO2004048411A3 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
03/10/2005WO2004041794A8 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
03/10/2005WO2004003166A3 Antibodies and uses thereof
03/10/2005WO2003104260A3 Pharmaceutical formulation
03/10/2005WO2003085089A3 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
03/10/2005WO2003073990A3 Treatment for asthma or allergies
03/10/2005WO2003010290A3 Novel class ii cytokine receptors and uses thereof
03/10/2005US20050054851 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
03/10/2005US20050054835 Immunoglobulin fusion comprising gelonin and shiga-like toxin for use in treatment and prevention of graft vs host, autoimmue and cell proliferative disorders
03/10/2005US20050054833 Immunoglobulin fusion for use in treatment and prevention of asthma, food allergies, sinus inflammation and vision defects
03/10/2005US20050054820 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy
03/10/2005US20050054726 Vaccine
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054703 Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
03/10/2005US20050054675 Interferon $g(g) production promoter
03/10/2005US20050054668 Antagonists of MCP-1 function and methods of use thereof
03/10/2005US20050054649 Probes for detecting the chaperone protein related to disease in biological samples; therapeutic treatment of cancer, autoimmune disease, inflammation, neurodegenerative disease, stroke, heart diseases
03/10/2005US20050054648 For therapy of cancer, including of breast neoplasma, endometrial cancer, colon cancer, and neck squamous cell carcinoma
03/10/2005US20050054624 Administering steroid9such as estrogen) containing hydrophobic substitution such as adamamtane ring; Alzheimer's, Parkinson's, Huntington's disease; multiple sclerosis; amyotropic lateral sclerosis; stroke; antiischemic agents
03/10/2005US20050054622 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound
03/10/2005US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders
03/10/2005US20050054601 Modified polynucleotides with phosphorothiolate linkage; animal growth regulators; immunomoderators; immunotherapy ; autoimmune disease
03/10/2005US20050054595 Genetic engineering; gene expression of target agent
03/10/2005US20050054594 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
03/10/2005US20050054587 Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseases
03/10/2005US20050054582 Para-amino benzoic acids as integrin antagonists
03/10/2005US20050054581 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
03/10/2005US20050054580 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
03/10/2005US20050054095 For treatment and/or prevention of inflammation and autoimmune disease; vaccines
03/10/2005US20050054090 MHC class II antigen-presenting systems and methods for activating CD4cells
03/10/2005US20050054074 Cell line comprising embryonated poultry cells and attenuated viral particles for use as tool in generation of vaccine for treatment and prevention of in fection by of influenza virus; immunotherapeutics
03/10/2005US20050054052 Therapeutic cytokine for use in prevention and treatment of viral diseases
03/10/2005US20050054041 Kini-3 motor protein and methods for its use
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050053627 Vaccines for Mycoplasma bovis and methods of use
03/10/2005US20050053622 Protecting cats against feline infectious peritonitis (FIP); fragments of an S protein of coronavirus
03/10/2005CA2824106A1 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005CA2765058A1 Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
03/10/2005CA2539953A1 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
03/10/2005CA2537093A1 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005CA2531506A1 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
03/09/2005EP1512739A1 Chrondrocyte therapeutic delivery system
03/09/2005EP1512695A1 Hypoallergenic polypeptides based on fish parvalbumin
03/09/2005EP1512694A1 Wasp venom allergens with reduced IgE-reactivity
03/09/2005EP1512404A1 External preparations for treating dermatitis
03/09/2005EP1512397A1 O-substituted hydroxyaryl derivatives
03/09/2005EP1512110A2 Screening process
03/09/2005EP1512014A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
03/09/2005EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
03/09/2005EP1511853A2 Regulation of novel human asparagine-hydroxylases
03/09/2005EP1511846A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
03/09/2005EP1511845A2 Immunostimulatory oligonucleotides and uses thereof
03/09/2005EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof.
03/09/2005EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators
03/09/2005EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors
03/09/2005EP1511742A1 Kinase inhibitors
03/09/2005EP1511737A1 Aryloximes
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511734A2 Compounds, compositions, and methods
03/09/2005EP1511732A1 Process for the manufacture of quinoline derivatives
03/09/2005EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
03/09/2005EP1511725A1 24-SULFOXIMINE VITAMIN D sb 3 /sb COMPOUNDS
03/09/2005EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/09/2005EP1511516A1 Topically applicable pharmaceutical preparation
03/09/2005EP1511509A1 Compositions and methods for treating diabetes
03/09/2005EP1511503A1 Use of a preparation produced from plant seedlings, enriched with electrolyte
03/09/2005EP1511502A2 Probiotic therapies using lactobacillus reuteri
03/09/2005EP1511499A2 Immunomodulatory compounds and methods of use thereof
03/09/2005EP1511496A1 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
03/09/2005EP1511481A1 Ophthalmological use of roflumilast for the treatment of diseases of the eye
03/09/2005EP1511478A2 Triptolide derivatives for modulation of apoptosis and immunosuppression
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005EP1511394A1 Probiotics and oral tolerance
03/09/2005EP1140112B1 Etherlysophospholipids for the treatment of chronic inflammatory diseases
03/09/2005EP1126849B1 Heterocyclic potassium channel inhibitors
03/09/2005EP0944645B1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME
03/09/2005EP0801679B1 Monoclonal antibodies which promote central nervous system remyelination
03/09/2005CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity
03/09/2005CN1592746A LFA-1 antagonist compounds
03/09/2005CN1592743A Inhibitors of glycogen synthase kinase 3
03/09/2005CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination
03/09/2005CN1592628A Compositions and methods for treatment of diabetes
03/09/2005CN1590408A Preparation technology of globe fish peptide and its medical health care use
03/09/2005CN1590403A Hexapeptide and its application
03/09/2005CN1590395A New type azesaccharide compound, their synthesis method and use as immune inhibitor and glycocidase inhibitor
03/09/2005CN1590394A New type trisaccharide and penta saccharid oligo saccharide antigen, their synthesis method and application in preparation of medicine for inhibiting exclusion reaction
03/09/2005CN1590375A TNF-alpha prodn. inhibitors
03/09/2005CN1590374A TNF-alpha prodn. inhibitors
03/09/2005CN1589905A Medical composition for treating desmosis and its use
03/09/2005CN1589900A Medical health protection use of globe fish glue
03/09/2005CN1589895A Anti virus health care product extracted from sea weed and its preparation method
03/09/2005CN1589815A Compound solanum lyratum injection agent for animal
03/09/2005CN1589812A Actire pilose deer horn, deer horn, deer bone nano powder and its preparation method
03/09/2005CN1589809A Chitin-nucleic acid immune regulation compound preparation
03/09/2005CN1192109C Anticoagulant fusion protein anchored to cell membrane
03/09/2005CN1192105C A variant of C6 beta-chemokine leukotactin-1(shLKn-1) with enhanced biological activity
03/09/2005CN1192099C Fermented vegetal material, its preparing process and use, and medical composition food additives containing the material
1 ... 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 ... 1172